New breast cancer combo sees success in New York trial
A new combination therapy designed for some of the most aggressive forms of breast cancer has shown promising results in…
All articles by Joshua Silverwood
Joshua Silverwood
-
-
Telix Pharma doses first patient in Phase III PET carcinoma trial
Australian biotechnology company, Telix Pharmaceuticals, has announced that it has dosed the first patient as part of its Phase III…
-
Shuttle Pharma announces glioblastoma trial expansion
Maryland-based drug discovery company Shuttle Pharma has announced the expansion of a Phase II trial of ropidoxuridine for glioblastoma patients…
-
Aulos Bioscience doses first patient in avelumab lung cancer trial
US-based immuno-oncology company Aulos Bioscience has announced the first patients have been dosed as part of a trial investigating avelumab,…
-
PTC Therapeutics ALS drug fails to meet endpoints as trials shut down
New Jersey-based biopharma, PTC Therapeutics said its Phase II trial of utreloxastat for patients with amyotrophic lateral sclerosis (ALS) has…
-
Axsome Therapeutics eyes approval after Phase III narcolepsy win
Axsome Therapeutics has announced that its investigational narcolepsy therapy has met the primary endpoint in a Phase III trial. AXS-12…
-
MaaT Pharma eyes Phase II after early success in ALS microbiome trial
French-based MaaT Pharma is eyeing up a Phase II study of its immune system modulator after its Phase Ib trial…
-
BioInteliSense remote cardiac device cuts hospital time in trial
Colorado remote patient monitoring firm, BioIntelliSense’s chest-mounted BioButton designed to monitor a range of vital signals can cut hospital times,…
-
Edwards Lifesciences announces positive results in one year TAVI trial
US medical device giant Edwards Lifesciences has said patients are experiencing “outstanding one-year outcomes” and lower rates of mortality after…
-
Patient dies in Neurogene’s Phase I/II Rett syndrome trial
A patient taking part in Neurogene’s Rett syndrome trial has died following complications from a rare hyperinflammatory syndrome associated with…